Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2334
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study ; volume:13 ; number:1 ; day:21 ; month:5 ; year:2013 ; pages:1-6 ; date:12.2013
BMC infectious diseases ; 13, Heft 1 (21.5.2013), 1-6, 12.2013

Urheber
Knudsen, Andreas
Beteiligte Personen und Organisationen
Møller, Holger Jon
Katzenstein, Terese L.
Gerstoft, Jan
Obel, Niels
Kronborg, Gitte
Benfield, Thomas
Kjaer, Andreas
Lebech, Anne-Mette
SpringerLink (Online service)

DOI
10.1186/1471-2334-13-230
URN
urn:nbn:de:1111-201603036661
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:20 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Knudsen, Andreas
  • Møller, Holger Jon
  • Katzenstein, Terese L.
  • Gerstoft, Jan
  • Obel, Niels
  • Kronborg, Gitte
  • Benfield, Thomas
  • Kjaer, Andreas
  • Lebech, Anne-Mette
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2

Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2

Soluble CD206 and CD163 as novel prognostic biomarkers in adult acute myeloid leukemia

Soluble CD206 and CD163 as novel prognostic biomarkers in adult acute myeloid leukemia

Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries

Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries

Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease

Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease

Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis

Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis

Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries

Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries

sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence

sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence

Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis

Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis

First-time Sensitive Homeomorphisms

First-time Sensitive Homeomorphisms

Untersuchungen zur Regulation des CD163-Gens

Hochschulschrift

Untersuchungen zur Regulation des CD163-Gens

Untersuchungen zur Regulation des CD163-Gens

Hochschulschrift | Online-Publikation

Untersuchungen zur Regulation des CD163-Gens

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease

Verbundene Objekte